India made Bharat Biotech's Covaxin found to be "93.4 percent effective" against severe symptomatic COVID19 cases in Phase-III trials. Covaxin is overall 77.8 percent effective against Covid, the vaccine maker said today. It also offers "65.2 percent protection" against the rapidly emerging Delta Variant. Watch the full story to know more!
